Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.
CAS Number:
[2231029-82-4]
Target:
COX
* VAT and and shipping costs not included. Errors and price changes excepted